Tertiary interventions are aimed at women who are about to go into preterm labor, rupture the membranes, or bleed preterm. The use of the
fibronectin test and ultrasonography improves the diagnostic accuracy and reduces false-positive diagnoses. While treatments to arrest early labor where there is progressive cervical dilatation and effacement will not be effective to gain sufficient time to allow the fetus to grow and mature further, it may defer delivery sufficiently to allow the mother to be brought to a specialized center that is equipped and staffed to handle preterm deliveries. In a hospital setting women are hydrated via intravenous infusion (as dehydration can lead to premature uterine contractions). If a baby has
cardiac arrest at birth and is less than 22 to 24 weeks gestational age, attempts at resuscitation are not generally indicated.
Steroids Severely premature infants may have underdeveloped lungs because they are not yet producing their own
surfactant. This can lead directly to
respiratory distress syndrome, also called hyaline membrane disease, in the neonate. To try to reduce the risk of this outcome, pregnant mothers with threatened premature delivery prior to 34 weeks are often administered at least one course of
glucocorticoids, an
antenatal steroid that crosses the placental barrier and stimulates the production of surfactant in the lungs of the baby. A Cochrane review from 2020 recommends the use of a single course of antenatal corticosteroids to accelerate fetal lung maturation in women at risk of preterm birth. Treatment with antenatal corticosteroids reduces the risk of perinatal death, neonatal death and respiratory distress syndrome and probably reduces the risk of IVH. Concerns about the adverse effects of prenatal corticosteroids include increased risk for maternal infection, difficulty with diabetic control, and possible long-term effects on neurodevelopmental outcomes for the infants. There is ongoing discussion about when steroids should be given (i.e., only antenatally or postnatally too) and for how long (i.e., single course or repeated administration). Despite these unknowns, there is a consensus that the benefits of a single course of prenatal glucocorticosteroids vastly outweigh the potential risks.
Antibiotics The routine administration of antibiotics to all women with threatened preterm labor reduces the risk of the baby being infected with
group B streptococcus and has been shown to reduce related mortality rates. When membranes rupture prematurely, obstetrical management looks for the development of labor and signs of infection. Prophylactic antibiotic administration has been shown to prolong pregnancy and reduce neonatal morbidity with rupture of membranes at less than 34 weeks. Because of concern about
necrotizing enterocolitis,
amoxicillin or
erythromycin has been recommended but not amoxicillin + clavulanic acid (
co-amoxiclav).
Tocolysis rarely delays delivery beyond 24–48 hours. This delay, however, may be sufficient to allow the pregnant woman to be transferred to a center specialized for management of preterm deliveries and give administered corticosteroids to reduce neonatal organ immaturity. Meta-analyses indicate that calcium-channel blockers and an oxytocin antagonist can delay delivery by 2–7 days, and
β2-agonist drugs delay by 48 hours but carry more side effects.
Magnesium sulfate does not appear to be useful to prevent preterm birth. Its use before delivery, however, does appear to decrease the risk of
cerebral palsy.
Mode of delivery The routine use of
caesarean section for early delivery of infants expected to have very low
birth weight is controversial, and a decision concerning the route and time of delivery probably needs to be made on a case-by-case basis.
Neonatal care In developed countries, premature infants are usually cared for in a
neonatal intensive care unit (NICU). The physicians who specialize in the care of very sick or premature babies are known as
neonatologists. In the NICU, premature babies are kept under radiant warmers or in
incubators (also called isolettes), which are
bassinets enclosed in plastic with climate control equipment designed to keep them warm and limit their exposure to germs. Modern neonatal intensive care involves sophisticated measurement of temperature, respiration, cardiac function,
oxygenation, and
brain activity. After delivery, plastic wraps or warm mattresses are useful to keep the infant warm on their way to the NICU. Treatments may include fluids and nutrition through
intravenous catheters,
oxygen supplementation,
mechanical ventilation support, and medications. In developing countries where advanced equipment and even electricity may not be available or reliable, simple measures such as
kangaroo care (skin-to-skin warming), encouraging
breastfeeding, and basic infection control measures can significantly reduce preterm
morbidity and mortality. Kangaroo mother care (KMC) can decrease the risk of neonatal sepsis, hypothermia, and hypoglycemia and increase exclusive breastfeeding.
Bili lights may also be used to treat
newborn jaundice (
hyperbilirubinemia). Water can be carefully provided to prevent dehydration, but not so much to increase the risks of side effects.
Breathing support In terms of respiratory support, there may be little or no difference in the risk of death or chronic lung disease between high flow nasal cannulae (HFNC) and
continuous positive airway pressure (CPAP) or nasal intermittent positive pressure ventilation (NPPV). For extremely preterm babies (born before 28 weeks' gestation), targeting a higher versus a lower oxygen saturation range makes little or no difference overall to the risk of death or major disability. Babies born before 32 weeks have been shown to have a lower risk of death from
bronchopulmonary dysplasia if they have CPAP immediately after being born, compared to receiving either supportive care or assisted ventilation. There is insufficient evidence for or against placing preterm stable twins in the same cot or incubator (co-bedding).
Nutrition Meeting the appropriate nutritional needs of preterm infants is important for long-term health. Optimal care may require a balance of meeting nutritional needs and preventing complications related to feeding. The ideal growth rate is not known; however, preterm infants usually require a higher energy intake compared to babies who are born at term. The recommended amount of milk is often prescribed based on approximated nutritional requirements of a similar-aged fetus who is not compromised. An immature
gastrointestinal tract (GI tract), medical conditions (or
co-morbidities), risk of aspirating milk, and
necrotizing enterocolitis may lead to difficulties in meeting this high nutritional demand, and many preterm infants have nutritional deficits that may result in growth restrictions. Tolerating a full enteral feeding (the prescribed volume of milk or formula) is a priority in neonatal care as this reduces the risks associated with
venous catheters, including infection, and may reduce the length of time the infant requires specialized care in the hospital. In the absence of evidence from randomised controlled trials about the effects of feeding preterm infants with formula compared with mother's own breast milk, data collected from other types of studies suggest that mother's own breast milk is likely to have advantages over formula in terms of the baby's growth and development. Supplementing human milk with extra protein may increase short-term growth, but the longer-term effects on body composition, growth and brain development are uncertain. Higher protein formula (between 3 and 4 grams of protein per kilo of body weight) may be more effective than low protein formula (less than 3 grams per kilo per day) for weight gain in formula-fed low-birth-weight infants. There is insufficient evidence about the effect on preterm babies' growth of supplementing human milk with carbohydrate, fat, and branched-chain amino acids. Conversely, there is some indication that preterm babies who cannot breastfeed may do better if they are fed only with diluted formula compared to full-strength formula, but the clinical trial evidence remains uncertain. Individualizing the nutrients and quantities used to fortify
enteral milk feeds in infants born with very low birth weight may lead to better short-term weight gain and growth, but the evidence is uncertain for longer-term outcomes and for the risk of serious illness and death. This includes targeted fortification (adjusting the level of nutrients in response to the results of a test on the breast milk) and adjustable fortification (adding nutrients based on testing the infant). Fortifier derived from humans is available; however, the evidence from clinical trials is uncertain, and it is not clear if there are any differences between human-derived fortifier and bovine-derived fortifier in terms of neonatal weight gain, feeding intolerance, infections, or the risk of death. Potential disadvantages of a more gradual approach to feeding preterm infants associated with less milk in the gut and include slower GI tract secretion of hormones and
gut motility and slower microbial colonization of the gut. The risks of feeding intolerance and necrotising enterocolitis related to early versus later fortification of human milk are not clear.
Intermittent feeding versus continuous feeding For infants who weigh less than 1500 grams, tube feeding is usually necessary. For infants who would benefit from intermittent bolus feeding, some infants may be fed using the "push feed" method, using a syringe to gently push the milk or formula into the stomach of the infant. Others may be fed using a gravity feeding system where the syringe is attached directly to a tube, and the milk or formula drips into the infant's stomach. It is not clear from medical studies which approach to intermittent bolus feeding is more effective or reduces adverse effects such as
apnea, bradycardia, or oxygen desaturation episodes.
High volume feeds High-volume (more than 180 mL per kilogram per day)
enteral feeds of fortified or non-fortified human breast milk or formula may improve weight gain while the pre-term infant is hospitalized; however, there is insufficient evidence to determine if this approach improves growth of the neonate and other clinical outcomes, including length of hospital stay.
Gastric residuals For preterm infants in neonatal intensive care on
gavage feeds, monitoring the volume and colour of gastric residuals, the milk and gastrointestinal secretions that remain in the stomach after a set amount of time, is a common standard of care practice. Gastric residual often contains gastric acid, hormones, enzymes, and other substances that may help improve digestion and mobility of the gastrointestinal tract. Hypernatraemia (sodium levels in the serum of more than 145-150 mmol/L) is common early on in preterm babies, and the risk of hyponatraemia (sodium levels of less than 135 nmol/L) increases after about a week of birth if left untreated and prevention approaches are not used. Well babies follow a 1-2-3-month benchmark timeline where they are screened, diagnosed, and receiving intervention for a hearing loss. However, for very premature babies, it might not be possible to complete a hearing screen at one month of age due to several factors. Once the baby is stable, an audiologic evaluation should be performed. For premature babies in the NICU, auditory brainstem response (ABR) testing is recommended. If the infant does not pass the screen, they should be referred for an audiologic evaluation by an audiologist. If the infant is on aminoglycosides such as gentamicin for less than five days, they should be monitored and have a follow-up 6–7 months of being discharged from the hospital to ensure there is no late onset hearing loss due to the medication. ==Outcomes and prognosis==